Detalles de la búsqueda
1.
Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.
Cancer Sci
; 115(2): 357-368, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38148492
2.
Clinical trends among patients with asthma hospitalized for COVID-19 based on data from a nationwide database: an observational study.
BMC Pulm Med
; 24(1): 105, 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38431557
3.
S-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.
Cancer Sci
; 114(2): 384-398, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285504
4.
Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.
J Immunol
; 206(6): 1204-1214, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504617
5.
Health Care Resource Use Among Patients with Advanced Non-Small Cell Lung Cancer in Japan, 2017-2019.
Curr Ther Res Clin Exp
; 99: 100712, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519418
6.
Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study.
Oncologist
; 27(7): e554-e560, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35325241
7.
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion.
BMC Cancer
; 22(1): 597, 2022 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650550
8.
Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan.
Biol Pharm Bull
; 45(3): 374-377, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35228403
9.
Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.
Cancer Sci
; 112(12): 4853-4866, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34628702
10.
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.
BMC Pulm Med
; 21(1): 373, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781910
11.
Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancer.
Cancer Sci
; 111(6): 1933-1942, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32277531
12.
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
Hum Mol Genet
; 26(2): 454-465, 2017 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28025329
13.
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
Int J Clin Oncol
; 24(5): 485-493, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30830659
14.
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.
Cancer Sci
; 109(9): 2852-2862, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29972716
15.
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.
Lancet
; 390(10089): 29-39, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28501140
16.
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF V600 mutation-positive solid tumors: a phase 1 study.
Invest New Drugs
; 36(2): 259-268, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28879519
17.
Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
Jpn J Clin Oncol
; 48(1): 82-88, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29136177
18.
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(5): 663-671, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28343976
19.
Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.
Cancer Sci
; 108(5): 1000-1006, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28266091
20.
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
Invest New Drugs
; 35(2): 207-216, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27928714